This compound is a deuterium-labeled derivative of nevirapine, an active pharmaceutical ingredient. It is primarily used as a reference standard in pharmaceutical research and quality control applications.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 1051418-95-1
Tetrabutylammonium acetate
Phase transfer catalyst
Risedronate 2-pyridinyl isomer
Pharmaceutical active ingredient impurity
Risedronic acid
bone resorption inhibitor
N-Acetyloxytocin
active pharmaceutical ingredient
2-cyclopropyl-7-(trideuteriomethyl)-2,4,9,15-tetrazatricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,12,14-hexaen-10-one
deuterated nevirapine intermediate
DISCONTINUED See N391278
stable isotope labeled pharmaceutical impurity
네비라핀
active pharmaceutical ingredient
2-Amino Nevirapine
active pharmaceutical ingredient impurity
7-methyl-2-(2,2,3,3-tetradeuteriocyclopropyl)-2,4,9,15-tetrazatricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,12,14-hexaen-10-one
NQDJXKOVJZTUJA-CQOLUAMGSA-N
[2H]C1(C(C1([2H])[2H])N2C3=C(C=CC=N3)C(=O)NC4=C(C=CN=C42)C)[2H]
—